Board Change • May 20
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Employee Representative Supervisor Jing Li is the most experienced director on the board, commencing their role in 2021. Independent Director Jin Hong Han was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Mar 30
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2026 Results on Apr 17, 2026 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2026 results on Apr 17, 2026 Tillkännagivande • Mar 19
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026, at 15:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China Tillkännagivande • Dec 26
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2025 Results on Mar 20, 2026 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2025 results on Mar 20, 2026 Tillkännagivande • Sep 30
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2025 Results on Oct 21, 2025 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2025 results on Oct 21, 2025 Tillkännagivande • Jun 30
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2025 Results on Aug 15, 2025 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2025 results on Aug 15, 2025 Tillkännagivande • Apr 17
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China Tillkännagivande • Mar 28
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025 Tillkännagivande • Feb 27
Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) entered into Equity Transfer Framework Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on July 2, 2024. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) signed the share purchase Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on December 11, 2024. A cash consideration valued at CNY 9.8 per share will be paid by Guangdong Hongda Holdings for 225,055,465 shares. The transaction is subject to approval or confirmation of the state-owned assets supervision and administration department, the State Administration for Market Regulation, the Shanghai Stock Exchange and other relevant competent authorities, and the application for share transfer registration through the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. As of December 11, 2024, the deal is subject to approval by the shareholders of Xinjiang Xuefeng Sci Tech(Group)Co.,Ltd and Guangdong Provincial State-owned Assets Supervision and Administration Commission. The acquisition has been approved by the Board of Directors of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd and Xinjiang State-owned Assets Supervision and Administration Commission. Xia Xiaohui of CITIC Securities Co., Ltd. acted as a financial advisor in the deal while Huang Xiaoli of Jun He Law Offices acted as the legal advisor to Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd. Guangdong Sinong Certified Public Accountants (Special General Partnership) acted as an accountant in the deal.
Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. on February 25, 2025. Tillkännagivande • Dec 27
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2024 Results on Apr 17, 2025 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2024 results on Apr 17, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.20 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥1.74b (up 1.6% from 3Q 2023). Net income: CN¥210.1m (down 11% from 3Q 2023). Profit margin: 12% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Buy Or Sell Opportunity • Oct 28
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 31% to CN¥8.55. The fair value is estimated to be CN¥7.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 19%. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥8.37, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 6.1% over the past year. Tillkännagivande • Sep 30
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2024 results on Oct 29, 2024 Reported Earnings • Aug 16
Second quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.26 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.25 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.64b (down 12% from 2Q 2023). Net income: CN¥266.5m (down 2.0% from 2Q 2023). Profit margin: 16% (up from 15% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Jun 28
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2024 Results on Aug 16, 2024 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2024 results on Aug 16, 2024 Tillkännagivande • Jun 06
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 1Q 2023). Revenue: CN¥1.18b (down 35% from 1Q 2023). Net income: CN¥125.3m (down 45% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Reported Earnings • Apr 12
Full year 2023 earnings released: EPS: CN¥0.82 (vs CN¥0.81 in FY 2022) Full year 2023 results: EPS: CN¥0.82 (up from CN¥0.81 in FY 2022). Revenue: CN¥7.02b (up 1.7% from FY 2022). Net income: CN¥853.5m (up 28% from FY 2022). Profit margin: 12% (up from 9.6% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Tillkännagivande • Mar 29
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥5.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Tillkännagivande • Dec 29
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2023 Results on Apr 11, 2024 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2023 results on Apr 11, 2024 Reported Earnings • Oct 21
Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.21 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥1.71b (up 49% from 3Q 2022). Net income: CN¥236.0m (up 59% from 3Q 2022). Profit margin: 14% (in line with 3Q 2022). Tillkännagivande • Sep 30
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2023 Results on Oct 27, 2023 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2023 results on Oct 27, 2023 Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2022). Revenue: CN¥1.85b (up 79% from 2Q 2022). Net income: CN¥271.9m (up 85% from 2Q 2022). Profit margin: 15% (in line with 2Q 2022). Tillkännagivande • Jun 28
Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2023 Results on Aug 18, 2023 Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2023 results on Aug 18, 2023 Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥10.22, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 29x in the Chemicals industry in China. Reported Earnings • Apr 28
Full year 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.20 in FY 2021) Full year 2022 results: EPS: CN¥0.81 (up from CN¥0.20 in FY 2021). Revenue: CN¥6.90b (up 165% from FY 2021). Net income: CN¥665.8m (up 356% from FY 2021). Profit margin: 9.6% (up from 5.6% in FY 2021). The increase in margin was driven by higher revenue. Board Change • Mar 15
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Zu Yi Yang was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 
